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Abstract
Background: The prevalence of Type 2 Diabetes (T2D) mellitus in the past decades, has reached epidemic
proportions. Several lines of evidence support the role of genetic variation in the pathogenesis of T2D and insulin
resistance. Elucidating these factors could contribute to developing new medical treatments and tools to identify
those most at risk. The aim of this study was to characterize the phenotypic response of the Collaborative Cross
(CC) mouse genetic resource population to high-fat diet (HFD) induced T2D-like disease to evluate its suitability for
this purpose.
Results: We studied 683 mice of 21 different lines of the CC population. Of these, 265 mice (149 males and 116
females) were challenged by HFD (42 % fat); and 384 mice (239 males and145 females) of 17 of the 21 lines were
reared as control group on standard Chow diet (18 % fat). Briefly, 8 week old mice were maintained on HFD until
20 weeks of age, and subsequently assessed by intraperitoneal glucose tolerance test (IPGTT). Biweekly body weight
(BW), body length (BL), waist circumstance (WC), and body mass index (BMI) were measured. On statistical analysis,
trait measurements taken at 20 weeks of age showed significant sex by diet interaction across the different lines
and traits. Consequently, males and females were analyzed, separately. Differences among lines were analyzed by
ANOVA and shown to be significant (P <0.05), for BW, WC, BMI, fasting blood glucose, and IPGTT-AUC. We use
these data to infer broad sense heritability adjusted for number of mice tested in each line; coefficient of genetic
variation; genetic correlations between the same trait in the two sexes, and phenotypic correlations between
different traits in the same sex.
Conclusions: These results are consistent with the hypothesis that host susceptibility to HFD-induced T2D is a
complex trait and controlled by multiple genetic factors and sex, and that the CC population can be a powerful
tool for genetic dissection of this trait.
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Background
In the past decades, the prevalence of Type 2 Diabetes
Mellitus (T2D) has reached epidemic proportions. Epi-
demiologic surveys show that to date, about 171 million
individuals have T2D worldwide, with projections of 366
million by 2030 [1, 2]. The increased incidence of T2D
coincides with an increase in obesity and metabolic syn-
drome (MTS). With a lag of about a decade, we are now
seeing the beginning of a far worse obesity/MTS/T2D
epidemic in Asia and South America similar to that ob-
served as Native American peoples adopted Westernized
lifestyles [3]. T2D, obesity and MTS are a heterogeneous
group of metabolic disorders characterized by defects of
both insulin secretion and insulin activity.
Several lines of evidence provide support for the role
of genetic variation in the pathogenesis of T2D and in-
sulin resistance [4–7]. Indeed, large resources dedicated
to investigate genetic epidemiology of T2D using data of
thousands of patients and matched control populations,
have identified numerous quantitative trait loci (QTL)
that affect susceptibility to T2D and MTS [8, 9]. Identifi-
cation of the underlying genes may help clarify the rela-
tionship of T2D and MTS [10, 11].
In addition to environmental and genetic predispos-
ition risk factors, sex-related differences were recognized
in the pathogenesis of T2D [12]. Men and women ex-
perience T2D and MTS, differently. In spite of multi-
plied expenses and time demands when conducting
research with both sexes, it is crucial to consider the
basic sex differences for providing new sex-specific ap-
proaches in prevention, diagnosis, and treatment of T2D
and related MTS features [13, 14].
The laboratory mouse is one of the most important tools
at our scientific disposal in understanding mammalian
gene function. The scientific community has taken advan-
tage of the fundamental similarity of mouse and man; at
the genetic level (99 % of mouse genes turn out to have
analogues in humans [15–17]), and mice and men share
similar physiology and anatomy. In genetically defined
strains of mice, chromosomal regions responsible for the
genetic variation of complex traits can be mapped as QTL
in experimental populations available for precise study
under defined conditions [18–20]. Once QTL have been
identified, genetic analysis can be extended successfully to
humans [21, 22]. It has been suggested that the variation
among extant strains of mice can be used for mapping
QTL associated with susceptibility to chronic and infec-
tious diseases [23–27]. In this context, T2D can be consid-
ered as a complex trait disease, where the challenge is the
high fat diet. Several previous studies have shown that
mouse strains differ substantially in their metabolic pheno-
type under normal relatively low-fat diet (LFD) conditions
and in response to a high-fat diet (HFD) and QTLs affect-
ing these traits have been mapped based on these mouse
strains [28–33]. In a previous linkage analyses study, QTLs
associated with dietary obesity were identified, by using the
C57BL/6byj X 129P3/J F2 mouse model [34]. They found
that allelic effects differed greatly depending on sex and
diet, demonstrating the importance of sex in the determin-
ation of dietary obesity in the mouse. Nevertheless, the use
of existing mouse strains to identify QTLs affecting T2D is
limited by the close relationships among the existing moue
strains, which limits the spectrum of QTL that can be un-
covered, and does not permit the high-resolution mapping
needed for positional cloning of the underlying genes. The
Collaborative Cross (CC) genetic reference population
(GRP), now in advanced stages of development by a com-
munity effort of the Complex Trait Consortium (CTC) was
designed to remove these limitations (CTC, www.complex-
trait.org). The CC was created by full reciprocal 8-way
matings of 8 divergent strains of mice: A/J, C57BL/6 J,
129S1/SvImJ, NOD/LtJ, NZO/HiLtJ, CAST/Ei, PWK/PhJ,
and WSB/EiJ. The founder strains of this population in-
clude three wild-derived inbred mouse strains (CAST/Ej,
PWK/hJ and WSB/EiJ), which introduce enormous genetic
and phenotypic diversity [35–37], while the designed struc-
ture of the CC lines allows the QTLs underlying this diver-
sity to be mapped with high power and high resolution
[38–41].
A cohort of CC RIL is now under development in our
laboratory at Tel Aviv University. As a first step towards
mapping genetic factors affecting HFD-induced T2D
development in CC mice, we have assessed 21 CC lines
after 12 weeks on a HFD (42 % fat content) and subse-
quently measured their Glucose tolerance by means of
fasting blood glucose and intraperitoneal glucose toler-
ance test (IPGTT). In parallel, a control cohort of 17 of
the same 21 CC lines, were maintained on standard
Chow diet (18 % fat). In contrast to most previous
studies, in our study we have equally assessed both sexes
of the CC lines.
It is well documented that there is a strong relation-
ship between overall Obesity (Body weight and BMI)
and Central Obesity (Waist circumference), and Type 2
Diabetes development. These reports show that overall
obesity by body weight (BW), body length (for BMI
calculation) and central obesity by waist circumference
(WC) can be strong predictors for T2D development
[43–45]. In the current study, we measured overall
Obesity by Body weight in grams and Body Mass Index
(BMI), while Central Obesity was measured by Waist
Circumference (WC). Type 2 Diabetes is a silent disease
that progress over long time at pre-symptomatic phase,
yet early detection of preclinical disease is possible
through monitoring of the glycemic stage of the body.
Higher levels of Fasting Glucose and GTT are strongly
associated with prediabetic conditions [46, 47]. Glycemic
stages range from Normoglycaemia stage (low risk) to
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diabetic stage, while prediabetic stage (high risk) is lo-
cated in between. Glycemic stage in our study was mea-
sured via fasting blood glucose (6 h fasting) and via
calculation of Area under curve across 180 min of a
Glucose tolerance test (IPGTT),
In the present study, we show that the HFD induces
increased body weight, waist circumference, BMI and
fasting glucose levels, and impairs Glucose tolerance.
We use these data to infer broad sense heritability of the
traits adjusted for number of mice tested in each line;
coefficient of genetic variation; genetic correlations be-
tween the same trait in the two sexes, and phenotypic
correlations between different traits in the same sex.
Methods
All experimental mice and protocols were approved by
the Institutional Animal Care and Use Committee of
Tel-Aviv University (approval numbers: M-07-084 and
M-012-025).
Collaborative cross mouse population
A total of 683 mice from 21 CC lines were used in the
study. In this experiment, we used large number mice,
so there will enough mice and power per line in each
diet and sex, as well to reduce the differences within a
line and obtain accurate traits. Of these, 265 mice (149
males and 116 females; average, 7.09 males and 5.52 fe-
males per line) were tested for HFD challenge, and 384
mice (239 males and 145 females; average 11.95 males
and 8.55 females per line) from 17 of the 21 lines were
used as control cohort on standard Chow diet. The dif-
ference in numbers between sexes and diets is a matter
of the mice that were available at the time. The mice
were provided by the Small Animal Facility at Sackler
Faculty of Medicine at Tel-Aviv University. The CC lines
were at inbreeding generations F10-F25, with a minimum
of 90 % homozygosity as determined by extensive high-
density genotyping. Full details of the development of
these CC lines are given in Iraqi et al. [39].
Determining the number of mice used in the study
This study had three objectives: (1) To show that a HFD
could cause development of biomarkers for T2D and
MTS in the CC mouse reference population with em-
phasis on uncovering gender x diet interaction effects; (2)
To demonstrate sufficient genetic variation in develop-
ment of T2D and MTS biomarkers among different lines
of the CC population to justify using the CC lines for
mapping of the relevant QTL; and (3) To (eventually)
characterize individual CC lines with respect to the multi-
trait development of these biomarkers For Objective (2) it
is clear that 10 lines would not be sufficient to obtain con-
vincing estimates of genetic variation among the CC lines,
while 50 lines is more than needed. This leads to choice of
20 lines. For Objective (3) it is clear that 1 or 2 animals
per line x gender combination would be too few to
characterize individual combinations for multi-trait com-
parisons, while 15–20 would probably be too much. We
took 8–10 as our goal. This led to planned totals of about
320–400 animals per treatment. Thus, for objective (1),
we had well over 100 animals for each diet x gender com-
bination. This should be sufficient to detect effects of
magnitude 0.25 s.d.u. with α = 0.05 and β = 0.20.
High fat dietary challenge
Mice were maintained from weaning (3 weeks of age)
until 8 weeks of age on the standard rodent Chow diet
TD.2018SC (3.1 kcal/gm), which consists of 18 % Kcal
from fat, 24 % from protein, and 58 % from carbohy-
drates (Teklad Global, Harlan Inc., Madison, WI, USA).
From 8 to 20 weeks, a cohort of mice was challenged by
a high-fat Western diet TD 88137 (4.5 kcal/gm), which
consists of 42.0 % Kcal from fat, 15.3 % from protein,
and 42.7 % from carbohydrates (primarily sucrose)
(Teklad Global, Harlan Inc., Madison, WI, USA). During
this challenge period, the control cohort continued to be
maintained on Chow diet. Mice had free access to water
and diet during the entire period.
Phenotyping
Body weight (BW), body length (BL), and body waist cir-
cumference (WC) were measured bi-weekly for each
animal in the HFD cohort. At the end of 12 weeks diet-
ary challenge, BW, BL and WC and intraperitoneal glu-
cose tolerance test were assessed for all animals from
both diets,
Intraperitoneal glucose tolerance test (IPGTT) and fasting
glucose
Mice were fasted for 6 h (6:00 AM −12:00 AM) with free
access to water. After 6 h fasting, blood glucose levels
were measured at time zero, before a solution of glucose
(2.5 g glucose per kg mouse) was administered by intra-
peritoneal (IP) injection [42, 48, 49]. Afterwards, the
blood glucose level was monitored by tail bleeding at
time 0, 15, 30, 60, 120 and 180 min after glucose injec-
tion, using U-RIGHT glucometer TD-4267 (TaiDoc
Technology Corporation 3 F, 5 F, No.127, Wungong 2nd
Rd., 24888 Wugu Township, Taipei County, Taiwan).
Area under curve for glucose tolerance (AUC)
An area under the curve (AUC) trapezoid model from 0
to 180 min after challenge was used to quantitatively
evaluate glucose clearance activity. AUC between any
two time points was calculated as (Time difference in
minutes between sequential reads)*(Glucose level 1st
time point + Glucose level 2nd time point)/2). In all
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cases, glucose level is measured from the level at time
zero to the end time point level (180 min).
Body weight (BW), Waist circumference (WC), Body length
(BL), and body mass index (BMI)
BW was measured with accuracy within 0.1 g. WC in
cm (accuracy to 0.1 cm) was taken manually around the
belly area midway between hip and thorax. BL in cm
(accuracy 0.1 cm) was taken manually nose to base of
the tail. BMI was calculated as BMI = BW/BL2
BW, WC, and BMI gain
BW, WC, and BMI gains were calculated as the difference
between the challenge end time-point value (20 weeks
old) minus the initial value (8 weeks old). Individual data
points were obtained at 8 weeks only for mice on HFD,
while at 20 weeks for all mice from both diets. Since CC
lines are highly inbred, the phenotypic values are more or
less interchangeable. On this assumption the mice on
Chow diet were assigned initial 8-week values randomly
from the pool of tested mice. This enabled calculations for
gain to be made for these animals as well.
Data analysis
Statistical Analysis was performed using the statis-
tical software package SPSS Version 22 (IBM SPSS
Statistics 22).
Two-way ANOVA by sex and diet examined the inde-
pendent effects of Sex and Diet and their interaction on
the different measured phenotypes. Data from all of the
lines for each Sex x Diet combination were pooled.
One-way ANOVA by lines was carried out separately
for each of the four Sex x Diet combinations. This pro-
vided data on significance of the differences among lines,
and for estimating broad sense heritability (H2) and co-
efficient of genetic variation (CVg).
Pearson Correlation coefficients between the different
measured traits were calculated by SPSS.
Broad sense heritability and the genetic coefficient of
variation (“Evolvability” parameter)
The phenotypes measured in the present study all fall
into the category of “Quantitative” (or “Complex”) traits.
Such traits typically display considerable phenotypic
variation (Vp) among the individuals of a population.
When analyzed appropriately this variation can be
decomposed into two sources, a genetic component of
variation (Vg) and an environmental component (Ve).
Thus, Vp = Vg + Ve. In principle, the genetic component
includes direct (“additive”) effects of the genes, and ef-
fects of dominance, epistasis, and gene x environment
interactions. Heritability refers to the proportion of
phenotypic variation among individuals that is contrib-
uted by the genetic component of variation.
Heritability ¼ Vg=Vp
Estimates of Vg from many types of experimental pop-
ulations and analyses include only additive genetic ef-
fects. In this case, the heritability estimate is termed a
“narrow-sense” heritability, denoted h2. If Vg includes
anything more than additive effects, the heritability esti-
mate is termed a “broad-sense” heritability, denoted H2.
In the CC populations, Vg includes epistatic and gene x
environmental effects, and hence it is a “broad sense”
heritability. In the present study, H2 was calculated from
the results of the One-Way ANOVA, as




H2 is the broad sense heritability for a particular diet x
sex combination,
Vg is the genetic variance component estimated from
the ANOVA for that combination as (MSbetween – Ve)/n
Ve is the environmental variance component, esti-
mated from the above ANOVA as MSwithin
n is the average number of mice per line for the par-
ticular diet x sex combination.
For example, consider the population composed of the
combined 149 male mice of the 21 CC lines on HFD diet
(i.e., the HFD x male-sex combination). The heritability
estimate for end-BW from the One-way ANOVA of this
population (0.47, Table 1), measures the proportion of
total phenotypic variation among these 149 mice that is
contributed by genetic factors segregating among the 21
lines. Full details of estimating trait heritability in our
CC lines were presented elsewhere [50].
We used the Genetic Coefficient of Variation (also
termed, the “evolvability” parameter) the ratio of the
genetic standard deviation (VG
0.5) to the mean across all
CC lines) as a unit-free measure of genetic variation for
comparison among traits [51, 52].
CVG ¼ VG0:5=Mean;
where,
VG is as defined above, and
Mean, is the unweighted mean trait value for the par-
ticular diet x sex combination across all CC lines.
CVG is of interest as providing a benchmark for judg-
ing whether VG values of traits in the CC lines are large
or small relative to VG values normally found in segre-
gating populations [53].
Heritability of line means (H2n)
The heritability of the trait in the study population tells us
the correlation between the observed phenotype of an in-
dividual in that population and the true genetic value of
the individual. Since the heritability is usually less than
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1.0, this means that an individual with given observed
phenotype, can have a true genetic value that varies more
or less widely about that phenotype. The statistical param-
eter that determines the potential variation in genetic
value, of an individual chosen on the basis of its pheno-
typic value, is the “coefficient of Non-determination” (also
termed the “coefficient of Alienation”) equal to (1-H2). For
a trait with H2 = 0.5, this means that the genetic value of
an individual can vary about its observed phenotypic value
with a variance equal to half of the genetic variance of the
entire population.
Often we are interested in identifying individual lines
showing high or low expression of a trait of interest, for
follow up physiological or genetic studies. In this case,
we choose the line of interest on the basis of the ob-
served mean trait value of the line. In this case, we de-
note by H2n the proportion of variation among the line
means that is due to genetic factors,. H2n is generally
considerably greater than H2, according to the following
expression, based on Robertson [54]:
H2 nð Þ ¼ nH2= 1 þ n‐1ð ÞH2 
Where, n is the mean number of individuals tested per
line. Examination of the expression shows that H2n be-
comes large rapidly with increase in n. That is, adding
more mice within each line gives us better and better
mean estimates of line genetic value until 100 % of the
variation in line means is explained by genetics (i.e.
H2n→ 1 as n→∞). For example, end-BW of male mice
on HFD had H2 = 0.47 on an individual mouse basis, but
there were on average 7.09 male mice per line, giving a
value of H2n = 0.86, meaning that 86 % of the variation
in line means results from genetic factors. The coeffi-
cient of non-determination for line means is only 0.16 in
this case, so that true line means vary in a narrow band
about the observed line mean.
Genetic and phenotypic correlations
The basic expression defining phenotypic and genetic
correlations among traits is derived in Falconer and
Mackay [55]. Using our notation for heritability and a *
to indicate multiplication, the expression has the follow-
ing form,
rPxy ¼ Hx Hy  rGxy þ Ex  Ey  rExy;
where,
rPxy is the phenotypic correlation between the two
traits X and Y based on individual measurements (not
on line means) of the two traits in the same individuals.
rGxy and rExy are genetic and environmental correla-
tions between the two traits respectively,
Hx and Hy are square root of heritabilities (H2x and
H2y) for X and Y, respectively,
Table 1 Broad sense heritability (H2) and genetic coefficient of variation (CVg) of the tested traits under high fat diet (HFD, 42 % fat)
and chow (CH, 18 % fat) diets, separately for females and males. Initial, end, trait value at start 8 weeks) and end (20 weeks) of HFD
challenge period. Gain, end trait-value minus initial trait-value. Total AUC, area under the curve for intraperitoneal glucose tolerance
test between 0 and 180 min from start of test. ND, not done (see text for explanations). Table 1 also shows H2n calculated for the
average animals per line (n) values of our data: 5.52 for females-HFD, 7.09 for males-HFD, 8.55 for females-Chow, and 11.95 for
males-Chow a
Trait Females Males
CH Diet HF Diet CH Diet HF Diet
H2 H2n CVg H2 H2n CVg H2 H2n CVg H2 H2n CVg
BW Initial 0.37 0.89 0.08 0.37 0.76 0.08 0.37 0.92 0.09 0.37 0.81 0.09
BMI Initial 0.47 0.92 0.14 0.47 0.83 0.14 0.33 0.90 0.09 0.33 0.78 0.09
WC Initial 0.54 0.94 0.13 0.54 0.87 0.13 0.38 0.92 0.10 0.38 0.81 0.10
BW End 0.57 0.95 0.14 0.56 0.88 0.16 0.55 0.96 0.16 0.47 0.86 0.15
BMI End 0.40 0.90 0.12 0.57 0.88 0.16 0.52 0.95 0.13 0.43 0.84 0.16
WC End 0.46 0.92 0.12 0.48 0.84 0.16 0.25 0.86 0.07 0.29 0.74 0.13
BW Gain 0.53 0.94 ND 0.51 0.85 ND 0.33 0.90 ND 0.38 0.81 ND
BMI Gain 0.56 0.94 ND 0.32 0.72 ND 0.24 0.85 ND 0.36 0.80 ND
WC Gain 0.56 0.94 ND 0.46 0.82 ND 0.11 0.70 ND 0.17 0.59 ND
Fasting Glucose 0.38 0.89 0.13 0.26 0.66 0.16 0.44 0.94 0.17 0.24 0.69 0.13
Total AUC 0.42 0.91 0.15 0.43 0.81 0.27 0.24 0.85 0.17 0.37 0.81 0.21
Mean 0.49 0.93 0.13 0.47 0.83 0.16 0.33 0.90 0.12 0.36 0.80 0.13
a No. of animals (in parentheses, mean number of animals per line): HFD, males and females, 21 lines, 116 females (5.52), 149 males (7.09); Chow diet, numbers
varied somewhat according to sex and trait. On average there were for males 20 lines average 11.95 mice per line; for females 17 lines, average 8,55 mice per line
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Ex and Ey are square root of coefficients of non-
determination (1-H2x) and (1-H2y), respectively,
Examination of the expression shows that if H2x and
H2y are high, rPxy will be primarily determined by rGxy,
while if H2x and H2y are low, rPxy will be primarily de-
termined by rExy.
When correlations are based on means of lines, the ex-
pression takes the form
rPnxy ¼ Hxn Hyn  rGxy þ Exn  Eyn  rExy;
where,
rPnxy is the phenotypic correlation between trait X
and trait Y based on means of n individual per line.
rGxy is the genetic correlation, as before,
Hxn and Hyn are square root of heritabilities (H2xn)
and (H2yn) of means of lines for the traits X and Y, where
H2xn and H2yn are calculated as in the previous section.
Exn and Eyn are square root of coefficients of non-
deermination (1-H2xn) and (1-H2yn) for traits X and Y
respectively.
Recall that H2n becomes larger with increasing n. It
necessarily ensues that E2n and its square root become
progressively smaller. Consequently, as n increases, the
expression Exn*Eyn*rExy becomes negligibly small, and
rPnxy ~Hxn*Hyn*rGxy.
Genetic correlation between the same trait in the two
sexes
The genetic correlation between the same trait in the
two sexes tells us the extent to which the same genetic
factors are operating in males and females. This is a spe-
cial case of the above, in which the same trait is mea-
sured in different individuals (males and females,
respectively). Consequently, there will not be any envir-
onmental correlation between the two measurements,
since they are taken on independent individuals with in-
dependent history of life events affecting the traits. Thus,
when correlations are based on means of lines for the
same trait in the two sexes (male, m; female, f ), the ex-
pression takes the form
rPnmf ¼ Hxnm Hxnf  rGmf
where
rPnmf is phenotypic correlation between the trait X in
males and trait X in females based on means of n indi-
vidual per line x sex combination.
rGmf is the genetic correlation between Trait X in
males and Trait X in females.
Solving for rGmf, we obtain,
rGmf ¼ rPnmf= Hxnm Hxnfð Þ
Hxnm and Hxnf are square root of heritabilities
(H2xnm) and (H2xnf ) of means of lines for the trait
X, where H2xnm and H2xnf are calculated as in the
previous section, separately for males (H2xnm) and
females (H2xnf ). For example, from Table 2 we find
phenotypic correlation under HFD between line
means for end BW for males and line means for end
BW for females = 0.734. From Table 1 we have H2nf
for end BW = 0.88 and H2nm = 0.86. Taking square
roots, we have rGmf = 0.734/(0.938*0.927) = 0.845.
Results
Two-way ANOVA, least square estimated effects by diet
and sex
Table 3 shows least squares estimated mean values for
the tested traits by diet and sex and their interaction, as
analzyed by two-Way ANOVA with diet and sex as main
effects. These are global effects of sex and diet and their
interaction, based on the combined data across all lines.
As will be seen, there are major differences among the
different lines in these effects. Because of very strong sex
x diet interaction effects, the estimates of the main ef-
fects of diet and sex provided by the Two-way ANOVA
analysis, are not meaningful. Hence, these main effect
estimates are not presented or discussed further.
Initial trait values
Since all animals were raised on Chow until 8 weeks of
age, there were no differences between the animals
assigned to the Chow diet treatment and those assigned
Table 2 Phenotypic (rPnmf) and genetic (rGmf) correlations
between the same traits in males and females on high fat diet
(HF Diet), based on line means for the given trait in males and
females a. BW, Body Weight; BMI, Body Mass Index; WC, Waist
circumference; Total AUC, total area under curve of the
intraperitoneal glucose tolerance test; Initial, measurements at
experiment start-point age of 8 weeks; End, end time- point of
the experiment after 12 weeks high-fat dietary challenge; Gain,
difference between end and initial time-point values
HF Diet
Trait rPnmf rGmf
BW Initial 0.626 0.797
BMI Initial 0.148 0.184
WC Initial 0.607 0.723
BW End 0.734 0.845
BMI End 0.705 0.819
WC End 0.414 0.525
BW Gain 0.646 0.776
BMI Gain 0.163 0.215
WC Gain 0.532 0.761
Fasting Glucose 0.338 0.500
Total AUC 0.542 0.672
a No. of animals: 21 lines all HFD, 149 males, 116 females
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to the HFD for initial BW, WC or BMI. There were, of
course significant differences at this age between males
and females assigned to the different diet groups. As can
be expected, females had lower BW and BMI and
smaller WC.
End trait values
For females, end-BW differed significantly on HFD com-
pared to Chow, but the differences were not large. End-
WC and end-BMI did not differ significantly and actual
differences were very small. For all three traits, end
values in males were significantly greater under HFD
than under Chow diets. This striking difference between
behavior of males and females, was expressed as a highly
significant sex x diet interaction term in the ANOVA.
Trait gain values
For females, BW gain under HFD was significantly
greater (+52.9 %) than under Chow diet. WC and BMI
did not differ significantly under the two diet treatments.
For all three traits, male gains were markedly greater
under HFD than under Chow diet (BW, +100.3 %; BMI,
+215.0 %; WC, +69.9 %). Here too, the stronger re-
sponse of males to HFD resulted in a highly significant
interaction effect.
Fasting glucose values
Fasting blood glucose levels were higher on Chow diet
for males than for females, and increased strongly on
HFD both for males and for females. Thus, in this in-
stance a significant interaction effect was not prsent.
Table 3 Least square estimated mean values for tested traits by diet and sex and their interaction. Dietary challenge from age 8–20
weeks. C, Chow diet (18 % fat); H, High fat diet (42 % fat); M, male; F, female; CM, males on chow diet; CF, females on Chow diet;
HM, males on high-fat diet; HF, females on high-fat diet. Above, estimated mean; in parentheses below, standard error (SE). Values in
the same row that share the same superscript letter do not differ significantly at P < 0.05. GxD, significance of Sex x Diet interaction.
RIF, increase on HFD relative to Chow, females; RIM, increase on HFD relative to Chow, males. NS, not significant. ND, not done, as
data are prior to HFD treatment e. BW, Body Weight; BMI, Body Mass Index; WC, Waist circumference; Total AUC, total area under
curve of the intraperitoneal glucose tolerance test; Initial, at experiment start-point age of 8 weeks; End, end time-point of the
experiment after 12 weeks high-fat dietary challenge; Gain, difference between end and initial time-point values
Trait CF HF CM HM SXD RIF RIM RIM/RIF
BW Initial 18.87a 18.92a 22.99b 22.92b
(0.31) (0.27) (0.24) (0.24) NS ND ND ND
BMI Initial 0.218a 0.216a 0.244b 0.243b NS ND ND ND
(0.005) (0.004) (0.004) (0.003)
WC Initial 5.90a 5.86a 6.69b 6.64b ND ND ND
(0.11) (0.1) (0.09) (0.09) NS
BW End 23.44a 25.52b 28.70c 34.35d
(0.65) (0.55) (0.5) (0.49) *** 1.089 1.197 1.099
BMI End 0.230a 0.230a 0.260b 0.310c
(0.006) (0.005) (0.005) (0.004) *** 1 1.192 1.192
WC End 6.77a 6.58a 7.92b 8.74c
(0.17) (0.15) (0.13) (0.13) *** 0.927 1.103 1.19
BW Gain 4.27a 6.53c 5.70bc 11.42d
(0.56) (0.48) (0.43) (0.42) *** 1.529 2.004 1.31
BMI Gain 0.011a 0.014a 0.020a 0.063b
(0.007) (0.006) (0.005) (0.005) *** 1.273 3.15 2.474
WC Gain 0.87ab 0.72a 1.23b 2.09c
(0.18) (0.15) (0.14) (0.14) *** 0.827 1.699 2.055
Fasting Glucose 146.15a 176.26c 163.17bc 206.58d
(3.86) (6.65) (3.35) (5.62) NS 1.206 1.266 1.05
Total AUC 25701.2a 37497c 32923.1b 53004.9d
(1126.7) (1224.4) (1069.7) (1080.4) *** 1.459 1.61 1.103
e No, of animals: for BW, BMI, WC: Chow Diet; females 16 lines, 85 animals; males, 20 lines 141 animals; HFD, females 21 lines 116 animals, males 21 lines 149
animals. For Fasting Glucose and AUC: Chow diet, 17 lines 137 females, 146 males; HFD 21 lines, 116 females, 149 males
***, P < 0.001
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AUC values show very much the same pattern as BW
gain. Females on HFD showed values significantly
greater than on Chow (+45.8 %), but their response was
exceeded by the males on HFD (+61.0 % relative to
males on Chow). Thus, here again the powerful inter-
action of diet and sex manifested, with males showing a
much stronger response to HFD than females.
Relative change on HFD compared to Chow for males and
females
Examination of the values in Table 3 shows that in many
cases, the absolute increase in trait value under HFD
compared to Chow seems to stand in proportion to the
trait value under Chow. That is, when trait values under
Chow are low, the increase from Chow diet to HFD is
low, and when Chow levels are high, the increase is high.
Since male trait values under Chow are generally greater
than female trait values, this alone can generate an inter-
action effect between sex and diet. To explore this fur-
ther, Table 3 also shows the relative increase in HFD
compared to Chow for females (RIF) and for males
(RIM) and their ratio (RIM/RIF). If increase on HFD is
proportional to Chow levels, then RIM/RIF will equal
1.0, indicating that males and females are responding in
the same proportional manner when Chow levels are
taken into account. In this event, the source of the inter-
action effect is the difference in starting Chow values for
males and females. Examination of Table 3, shows that
this is indeed the case for fasting glucose levels, and to
some extent for end BW and for AUC. But for all other
traits, in particular BMI gain and WC gain, the effect of
HFD in males is greater than in females, even when
standardized against starting Chow values, indicating a
true sex x diet interaction. Thus, under HFD challenge,
at the physical level, females and males respond very dif-
ferently: female mice remain lean, while males become
obese, But at a deeper biochemical level, both sexes ap-
pear to react the same, showing more or less equivalent
proportional increases in fasting glucose and IPGTT
AUC levels.
Variation among lines for end-BW, fasting blood glucose
and IPGTT AUC
Table 3 presents global effect of diet and sex across all
lines. To show effects of the individual lines, Figs. 1, 2, 3,
and 4 present behavior of the individual lines by sex and
diet with respect to BW, fasting blood glucose, IPGTT-
AUC and kinetics of IPGTT. In all cases, the line x sex x
diet values represent the mean values of a number of in-
dividuals of each sex in each line as given in Materials
and Methods.
In Figs. 1, 2, 3, Bar Charts A and B represent trait
values for males and females, respectively; Bar Charts C
and D shows differences between males and females
under Chow and HFD, respectively; and Bar Charts E
and F show differences between Chow and HFD for fe-
males and males, respectively. Inspection of the bar
charts of Figs. 1, 2 and 3 shows that within the general
effects of sex and diet shown in Table 3, there was tre-
mendous variation among lines for the actual trait
values, and for the effects of sex and diet on trait values.
Figure 1 emphasizes the ability of females and males
of some lines to maintain close to normal BW even
under HFD. For females under HFD (Bar Chart E), 11
out of the 17 lines did not differ appreciably, or gained
even less than females under Chow. Even for males six
of the lines under HFD, did not differ appreciably or at
all from their line-mates under Chow. For five of these
lines, females also did not differ under Chow and HFD.
Thus, these lines are apparently able to control BW
gains even under HFD challenge.
Figure 2 presents Bar charts showing fasting blood
glucose values for females and males of the individual
CC lines after 12 weeks dietary challenge. Most female
lines show minor response to HFD; with a few lines
showing moderate to strong responses (see also Bar
chart E). For males, all lines but one, show moderate to
strong response to HFD (see also Bar chart F). Bar
charts C, D show differences between sexes under Chow
and HFD, respectively. Under Chow differences are
small, but generally favor males. Under HFD, with two
strong exceptions, males show clearly higher values than
females.
Figure 3 presents graphs showing the kinetics of
IPGTT for the individual CC lines separately for females
and males, after 12 weeks dietary challenge. Blood glu-
cose levels reached peak value at 20–30 min, and there-
after began to decline, either immediately or after a
more or less extended plateau period. With some excep-
tions, initial 0 time levels were approached but not
reached by the end of the test period (180) minutes. For
both males and females there was a clear increase in
peak glucose values under HFD, in addition to a major
increase in post-peak plateau periods.
On average across lines under Chow diet, peak values
for males were slightly greater than for females, but
overall responses of males and females were within the
same range. Under HFD peak, values of males and fe-
males increased by about the same amount averaged
across lines. However, males averaged an appreciably
longer post-peak plateau period than females. Remark-
ably, for the males, the variation among lines became
smaller on HFD compared to Chow, while the females
showed marked increase in between line variation on
HFD. Males were uniformly affected by the HFD; fe-
males less so on average, but very variable, with some
lines essentially unaffected, other lines reacting as
strongly as males.
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Figure 4 presents Bar charts showing total area under
the curve (AUC) for Chow and HFD diets of females
and males, respectively, by lines. With one exception, all
lines responded to the HFD by an increase in AUC. The
increase, for females was generally small, with one or
two exceptions, while all male lines showed a large in-
crease in AUC
Bar graphs C and D show difference between males
and females under Chow diet (C) and HFD (D), respect-
ively. Under Chow diet, males tend to show somewhat
higher AUC than females, but the differences are small
or negative. Converesly, under HFD most lines show a
marked increase in males compared to females. Even
here for a few lines the difference is small or even nega-
tive. Finally, bar graphs (E) and (F) show difference be-
tween HFD and Chow for females (E) and males (F). For
females, differences are generally small, and in one case
negative. For the males, all differences are postive and
generally appreciable.
Kinetics of BW and possibility of two-stage growth curves
Figure 5 presents graphs and bar charts showing kinetics
of BW of females and males of the individual CC lines
from 8 to 20 weeks on HFD. The graphs show that both
sexes gain weight for the first 6 weeks on HFD. For the
second 6 weeks, while males of all lines continue to gain
weight; some of the female lines do not gain weight or
even lose weight.
Bar chart C shows the BW gains across the first
6 weeks on HFD, separately for males and females of
the 21 CC lines. The CC lines are ordered according
to male weight gain in this period and the gains of
their female counterparts are shown alongside.
Fig. 1 End time point Body Weight (g) of 17 CC lines separately for females and males, after 12 weeks on Chow diet (CH, 18 % fat) and on high
fat diet (HFD, 42 % fat). Bar graphs a and b show end time point Body Weight means (±SE) for CH and HFD of females and males, respectively,
by lines. Bar graphs c and d, show diference between males and females for Chow (ΔCH =Males-Females) and HFD (ΔHF = Males-Females),
respectively. Bar graphs e and f show differences between CH and HFD for females (ΔDiets/Females = HF-CH) and males (ΔDiets/Males = HF-CH),
respectively. No. of animals: HFD, 128 males, 102 females; Chow, 146 males, 137 females
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Weight gains in the second 6 weeks are shown in Bar
chart D. The difference in gain in the second 6-week
period (Bar chart D) compared to the first 6-week
period (Bar chart C) is dramatic; male weight gains
were very small, and none were comparable to those
in the first 6 weeks. Female weight gains ceased or
were very slight; a number of lines even showing a
small decrease in weight.
Bar chart E shows difference in body weight gain for
first 6 weeks on HFD between males and females. Differ-
ences were small for the males and females of the low
male-gain lines; much larger for the males and females
of the moderate to high male-gain lines.
Bar charts D and F show corresponding values for
the body weight gain on HFD second period, showing
tendency for lines with high male gains in the first
period to have higher gains in the second period for
both sexes. The lines for which the females lost or
gained little weight were concentrated in the lower
half of the male lines in the first period. Bar chart F
shows small or even negative differences between
males and female gains for many lines, while for
other lines differences were large. Interestingly, a few
lines that show moderate increase in gains in the first
period, show higher increase in the second period
(e.g. IL2126, IL72, IL1513, IL3480). This phenomenon
Fig. 2 Fasting Glucose levels (mg/dL) of 17 CC lines separately for females and males, after 12 weeks on Chow diet (CH, 18 % fat) and on high
fat diet (HFD, 42 % fat) measured at time 0 before IPGTT glucose injection. Bar graphs a and b show Fasting Glucose level means (±SE) for Chow
and HFD of females and males, respectively, by lines. Bar graphs c and d, show diference between males and females for Chow (ΔCH =Males-
Females) and HFD (ΔHF =Males-Females), respectively. Bar graphs e and f show differences between Chow and HFD for females (ΔDiets/
Females = HF-CH) and males (ΔDiets/Males = HF-CH), respectively. No. of animals: HFD, 128 males, 102 females; Chow, 146 males, 137 females
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may reflect different metabolic mechanisms at differ-
ent time points of development (see Discussion).
One-way ANOVA, differences among lines
Figures 1–5 display extensive variation among CC lines
for the measured phenotypes. Similar variation was also
found for the other measured traits (data not shown).
For significance of the variation, One-Way ANOVA for
the complete set of traits was calculated, separately for
each of the four sex x diet combinations. In all cases,
differences among lines were significant at P < 0.05 to P
< 0.001, and the extreme high and low value lines for
any given trait differed significantly by Duncan’s multiple
range test (see Additional file 1: Figure S1 and S2)
Fig. 3 Kinetics of Intraperitoneal glucose tolerance test (IPGTT) showing mean blood glucose level (±SE) at different time points during 180 min
test. Data are shown for 17 CC lines, separately for males and females, at age 20 weeks after 12 weeks on Chow diet (CH, 18 % fat) and on high
fat diet (HFD, 42 % fat). Blood glucose levels were measured at time 0, 15, 30, 60, 120 and 180 min after glucose injection. The dark central line
shows average glucose levels across lines. Chart a, Males-Chow; b, males-HFD; c, females-Chow; d, females-HFD. No. of animals: HFD, 128 males,
102 females; Chow, 146 males, 137 females
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Broad sense heritability and genetic coefficient of
variation
Table 1 shows broad sense heritability (H2) and genetic
coefficient of variation (CVg) of all tested traits; calcu-
lated separately by sexes and diets. CVg was not calcu-
lated for the “gain” traits, since the gain values varied
from positive to negative. Consequently, the mean gain
was small while genetic variation (VG) was large. Owing
to this, the calculated values for CVg of the gain traits
were often greater than 1.00 and were essentially mean-
ingless. As noted above, initial trait values for both diets
are the same. Heritability values were generally moder-
ate, in the range 0.24 to 0.57. Heritabilities for a given
sex x trait combination under Chow and HFD were
generally quite similar. Heritabilities for females (mean
0.480) were greater than males (mean 0.344), under both
diets. CVg values range was 0.08 to 0.27, but most values
were in the range 0.09 to 0.20. CVg values for initial BW
were always the lowest and those for AUC the highest,
for any sex x diet combination.
Table 1 also shows H2n values calculated and adjusted
for the number of animals in each sex x diet group. The
H2n values are very high, indicating that the observed
varation among the line trait-means is primarily due to
genetic factors, and not to environmental factors. The
differences in mean H2n values between sexes is mostly
due to the different mean line numbers for males and fe-
males under the different diets, e. g., for females mean
Fig. 4 Blood glucose levels (mg/dL) during intraperitoneal glucose tolerance test (IPGTT) of 17 CC lines separately for females and males, after
12 weeks on Chow diet (18 % fat) and on high fat diet (HFD, 42 % fat) measured at time 0, 15, 30, 60, 120 and180 min after glucose injection. Bar
graphs a and b show means (±SE) of total area under the curve (AUC) for Chow and HFD of females and males, respectively, by lines. Bar graphs
c and d, show diference between males and females for Chow (ΔCH =Males-Females) and HFD (ΔHF =Males-Females), respectively. Bar graphs
e and f show differences between Chow and HFD for females (ΔDiets/Females = HF-CH) and males (ΔDiets/Males = HF-CH), respectively. No. of
animals: HFD, 128 males, 102 females; Chow, 146 males, 137 females
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H2 is very similar under CH (0.49) and HFD (0.47);
while H2n is appreciably less under HFD (0.83) than
under CH (0.93), reflecting the larger number of females
per line under CH (8.55) compared to HFD (5.52).
Genetic correlations among the same trait in the two
sexes
Table 2 shows phenotypic (rPnmf) and genetic (rGmf)
correlations for the same traits in males and females.
The cross sex genetic correlations for BW are high, indi-
cating that all through the experimental period, 70 % to
80 % of the genetic factors controlling BW are common
to males and females. Cross-sex genetic correlations for
WC, fasting glucose and AUC are less, in the range 50
to 70 %, indicating influence of sex-specific factors. BMI
shows very high cross-sex correlations for end BMI but
very low correlation for initial BMI. Consequently, gen-
etic correlation for BMI gain is also very low.
Fig. 5 Kinetics of Body Weight (g) means (±SE) of females (a) and males (b) of 21 CC lines from 0 to 12 weeks on high fat diet (HFD, 42 % fat).
c and d, bar graphs showing mean gains (±SE) on HFD of males and females weeks 0 to 6 and 7 to 12, respectively; lines ordered according to
male gains from 0 to 6 weeks. e and f, bar graphs showing differences between males and females in weight gains from 0 to 6 and from 7 to
12 weeks on HFD, respectively. No. of animals: 149 males, 116 females
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Phenotypic correlations among different traits within
sexes
Table 4 shows the phenotypic correlations among the
various traits within sexes, separately for males and fe-
males. Considering females, there were moderate to
high positive correlations among all body measurement
traits, except initial BMI, which had low and even nega-
tive correlations with all other body and gain measure-
ments. IPGTT had low correlations with most body
traits, and slightly negative correlations with initial BW
and initial BMI. However, there were high correlations
with BW and BMI gain, although not with WC gain.
Fasting glucose levels had moderate positive correla-
tions with end BW and BW gain and high correlation
(r = 0.597, P < 0.01) with Total AUC.
Considering the males, there were moderate to high
positive correlations among all of the body traits. Here
too, initial BMI was lowly correlated with other traits,
and negatively correlated with BMI gain. High correla-
tions were found between initial BW and the other body
measurements. Indeed, correlations among the body
traits were generally higher for the males than for the fe-
males, especially for correlations of initial and end BW
with other traits. Correlations between IPGTT and body
traits were preponderantly low negative, with some low
positive. IPGTT correlated negatively with BMI gain,
and low positively with BW and WC gain; similarly for
Fasting glucose levels.
Summarizing main inferences of Table 4, initial BW
explained most variation in body traits in males, while in
females it was end BW. Fasting glucose levels and total
AUC were highly positive correlated in both sexes. BW
gain and BMI gain were predictive of AUC in females,
but not in males.
Overall, the extremely susceptible CC lines towards
development of both obesity and glucose tolerance in re-
sponse to HF dietary challenge are IL-4457, IL-188, IL-
1513, IL-2573, IL-4141 and IL-2750 of both sexes.
Additional CC lines with similar susceptibility but sex-
dependent are, females of IL-519, IL-3912 and males of
IL-1912, IL-2011, IL-2680, and IL-4052. The only ex-
tremely resistible CC lines towards, both development of
obesity and impaired glucose tolerance in response to
HF diet were only females of IL-2680 and IL-4052 (mod-
erate). On other hand, CC lines that exhibit extreme
resistibility towards obesity with extreme/moderate sus-
ceptibility towards impaired glucose tolerance are, IL-72,
IL-111, IL-2126 and IL-2689 of both sexes, only males
of IL-519 and IL3912, and only females of IL-1912, IL-
2011 and IL-4156.
Discussion
Metabolic syndrome (MTS) is a collection of risk fac-
tors, including central obesity, reduced HDL;along with
high blood pressure, triglycerides, and fasting blood glu-
cose levels, that increase likelihood of T2D [51, 52]. The
current model for the causative pathway, leads from BW
gain in response to high fat diet (HFD) to central obes-
ity, and from there to insulin resistance and high fasting
blood-glucose levels [44, 53]. The latter are thought
to have inflammatory effects on many body systems,
leading to T2D and metabolic syndrome complications,
expressed as insulin resistance with inflammation-
impaired pancreatic beta-cell function reflected as
Table 4 Correlation matrix between line means of all traits on high-fat dietary challenge (HFD, 42 % fat) within sexes (females, above
the diagonal; males, below the diagonal) a. BW, Body Weight; BMI, Body Mass Index; WC, Waist circumference; Total AUC, total area
under curve of the intraperitoneal glucose tolerance test; Initial, measurements at experiment start-point age of 8 weeks; End, end
time-point of the experiment after 12 weeks high-fat dietary challenge; Gain, difference between end and initial time-point values
Trait BW Initial BMI Initial WC Initial BW End BMI End WC End BW Gain BMI Gain WC Gain Fasting Glucose Total AUC
BW Initial 1 0.227 0.520* 0.636** 0.507* 0.550** 0.280 0.266 0.148 0.003 −0.171
BMI Initial 0.435* 1 0.010 −0.110 0.188 −0.153 −0.253 −0.557** −0.165 −0.142 −0.350
WC Initial 0.728** 0.301 1 0.406 0.506* 0.417 0.240 0.421 −0.371 0.172 0.254
BW End 0.875** 0.473* 0.660** 1 0.778** 0.828** 0.919** 0.737** 0.522* 0.208 0.345
BMI End 0.778** 0.342 0.688** 0.827** 1 0.678** 0.709** 0.711** 0.290 0.070 0.274
WC End 0.735** 0.446* 0.591** 0.816** 0.715** 1 0.749** 0.684** 0.690** 0.094 0.379
BW Gain 0.710** 0.443* 0.551** 0.962** 0.765** 0.773** 1 0.781** 0.574** 0.257 0.517*
BMI Gain 0.594** −0.155 0.568** 0.626** 0.875** 0.522* 0.576** 1 0.363 0.161 0.482*
WC Gain 0.355 0.322 −0.032 0.506* 0.360 0.788** 0.537* 0.213 1 −0.041 0.185
Fasting Glucose −0.121 0.176 −0.315 −0.085 −0.310 0.020 −0.056 −0.416 0.265 1 0.597**
Total AUC −0.347 0.101 −0.171 −0.106 −0.316 −0.026 0.042 −0.384 0.098 0.585** 1
a No. of animals: 21 lines all HFD, 149 males, 116 females
*, P < 0.05; **, P < 0.01
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impaired Glucose tolerance during an intraperitoneal
glucose tolerance test (IPGTT) [54, 55].
The major objective of the present study was to assess
the suitability of the novel and genetically highly diverse
mouse CC genetic reference population [39, 61, 62], as a
model system for exploring genetics of MTS and T2D.
For this, we compared responses to HFD and standard
Chow diets with respect to development of these condi-
tions in cohorts of the CC lines. We monitored body
weight gain, abdominal obesity as measured by body mass
index (BMI) and body waist circumference (WC) due to
their central role in etiology of MTS; and fasting glucose
levels and IPGTT test for glucose tolerance measured by
total area under the curve (AUC). We asked whether
HFD induces changes typical of MTS and T2D; whether
there were sex differences in response to HFD as found in
humans; and whether there was abundant genetic vari-
ation to provide good chances for successful genomic ana-
lysis to the level of the individual gene.
Dietary effects on development of impaired fasting
glucose and IPGTT in the CC mice
Mice reared on the HFD showed clear development of
physical and biochemical biomarkers for MTS, which
agreed with a previously published study [63]. However,
in our study, development of the physical markers was
much more pronounced for males than for females. As
shown in Table 3, under HFD, males presented gains in
BW, BMI and WC that were, respectively 2.00-, 3.15-,
and 1.70-fold greater than for males under Chow diet.
The corresponding values for females were 1.53, 1.27-,
and 0.83-fold thus aside from BW gain, HFD had little
effect on physical markers in females. This sex difference
may be a reflection of the greater BW gains of the males
under HFD (two-fold greater than under Chow) as com-
pared to females (only 1.53-fold greater than under
Chow), which might be sufficient to tip males over the
edge to obesity while keeping females lean. In contrast,
the strong effect of HFD on fasting glucose levels for fe-
males (relative to Chow) was proportionately the same
as for males. Thus, HFD was very effective in generating
MTS-like condition in both sexes as judged by insulin
resistance. Similarly, an accepted diagnostic criterion for
T2D is impaired glucose clearance after high glucose
load challenge by intraperitoneal glucose injection.
Figure 3 shows that for the most part, on Chow diet
both sexes succeed in returning glucose levels close to
normal by 180 min following IPGTT challenge; while
the mice on HFD mice failed to do so. Total AUC from
0 to 180 min as a quantitative measure for glucose toler-
ance reveals that on average across all lines for both
sexes, the HFD mice showed significantly reduced glu-
cose tolerance, as shown by greatly increased AUC rela-
tive to standard Chow diet mice. Thus, HFD clearly
induces a T2D-like condition in these mice, and was
only a bit less effective in females as in males.
Phenotypic and genetic correlations among traits
Examining the full matrix of phenotypic correlations
within sexes for the different traits in response to HFD
presents an intriguing picture (Table 4). For both sexes,
there is a strong positive correlation between BW gain
and obesity measures (BMI and WC). In females but not
males, this continues with positive association of BW
gain, BMI gain (although not WC gain) with fasting
blood glucose levels and AUC. This is consistent with
the suggestion that increase in body weight is a key ab-
normality predisposing to insulin resistance [64, 65]. Re-
markably, in males, BMI was negatively correlated
(although not significantly) with Glucose tolerance traits.
We speculate that this may to be due to threshold ef-
fects of BW gain on development of insulin resistance.
To wit, that below a certain threshold, there is a mono-
tonic relation between obesity (as measured by BMI) or
BW gain and insulin resistance; but above this level, BW
gain has exerted its maximum effect, and there is no fur-
ther relation between degrees of BW gain and degree of
insulin resistance. We propose that for females, develop-
ment of obesity for most CC lines under our experimen-
tal conditions is below the threshold, exposing the
positive correlation between obesity and insulin resist-
ance; while for males, development of obesity for most
lines is above the threshold.
Genetic correlations between the physical markers
across the two sexes were high for BW and WC; some-
what erratic for BMI (Table 2). Thus, for the most part
the same genetic factors appear to govern the effect of
HFD on BW and obesity by WC and BMI in the two
sexes, although the absolute impact of HFD on obesity
differs between sexes, as described above. The situation
is different for fasting glucose and AUC, with cross-sex
genetic correlations equal 0.497 and 0.670, respectively.
For these traits, there appears to be a greater presence
of sex-specific genetic factors that modify the response
to HFD.
Genetic variation in dietary effects among the CC lines
The dietary and sex effects discussed above represent
overall average effects of diet and sex, with wide variation
among the lines, as emphasized in the graphs of BW
kinetics of the CC lines (Fig. 5) and Glucose clearance
kinetics during IPGTT (Fig. 3). More detailed bar charts
presentations (Figs. 1, 2 and 4), show wide variation
among lines in end BW, fasting glucose and total AUC.
The variation is expressed in absolute values of males
and females of the individual lines according to diet; in
differences between males and females by diets; and in
llldifferences in dietary effects in males and in females.
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Under Chow diet, for 6 of 17 lines, both sexes were
able to return blood glucose levels to initial fasting levels
by the end of the IPGTT test at 180 min. The same was
found for females but not males of 3 additional lines.
Under HFD, for 6 of the lines, females were able to re-
turn to initial levels at 180 min, but for none of the lines
were the males able to do so. Even of the 6 lines for
which females returned to starting levels under HFD,
five showed greater fasting glucose levels under HFD
under Chow diet, for females. Thus, there was one line
where females maintained normal fasting levels and
returned to initial levels after challenge under HFD. This
line also had males that returned to initial levels at
180 min under Chow, but not under HFD. Thus, this
was a very resistant line, but still susceptible to HFD in-
duced impaired glucose metabolism to some extent.
Broad sense heritability coefficients (H2) based on in-
dividual mice are in the moderate range, indicating that
at the level of the individual mouse, the target traits are
affected more or less equally by genetic and environ-
mental factors and their interaction. At the level of the
line, however, heritability coefficients (H2n) are very
high, indicating that the observed variation among line-
means described above, is primarily genetic in origin.
The genetic coefficient of variation (CVG) ranges from
0.07 to 0.27, but most values are in the range 0.12 to
0.17. This is about twice the value found for most quan-
titative traits in wild or domesticated animal popula-
tions. Thus, in this case also, the CC lines appear to
have incorporated a massive amount of genetic diversity.
In all likelihood, this is due to the inclusion of the three
wild-derived strains and subspecies among the founder
lines of the CC population. For all diet x sex combina-
tions, CVG was least for initial BW, and greatest for
AUC. Initial BW (i.e., BW under standard diet) is under
strong stabilizing selection in the wild, and would not be
expected to show a great deal of genetic variation, even
in wild accessions. In contrast, AUC is a trait that would
not be under any degree of selection in the wild, and
hence can be expected to show a great deal of variation
when exposed to challenge. These effects parallel to the
well-known observation that naïve human populations
exposed to the Western diet tend to develop extreme
obesity and MTS health complications. It would be of
interest to explore whether there is also great variation
in degree of obesity in these populations.
Categorical or quantitative?
The susceptibility of different mouse strains to diet-
induced obesity and insulin resistance will be partly re-
lated to genetic difference in variables linked to energy
balance and glucose homeostasis [66–68]. In addition,
the response of different mouse strains will be highly
dependent on feeding duration, diet composition and
housing conditions. Variations in these experimental pa-
rameters may explain why previous studies have charac-
terized commercial inbred lines as either prone to
obesity and insulin resistance [28, 66], or relatively re-
sistant to the effects accompanying an HFD [66, 69].
The strength of our study is that all CC lines were stud-
ied under the same experimental conditions and both
sexes were analyzed, as well. Comparing the various
lines, it is clear that the variation in our population of
lines is quantitative rather than categorical. That is, the
lines differ in a quantitative way along a spectrum of
values for the various traits measures. The differences
among lines with respect to the measured traits do not
behave in an “all or none” manner
Two-stage regulation of body weight gain
As noted, the major body weight changes were observed
during the first 6 weeks on HFD in both sexes, with
higher gains in males as shown Fig. 5. These changes
were less in the remaining 6 weeks of the experiment.
After 6 weeks on HFD females appear to be able to de-
fend against further increase in BW, while males con-
tinue to increase in BW over the entire experimental
period. Figure 6a (males) and b (females) present the
Fig. 6 Scattergrams showing regression of Body Weight (BW) gain
in weeks 7 – 12 on Body Weight (BW) gain in weeks 0–6 on High-
Fat diet (HFD, 42 % fat) by line means for 21 lines. Chart a, males; b,
females. No of animals, 149 males, 116 females
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regression of BW gain in weeks 7–12 on BW gain in
weeks 0–6 on HFD challenge for both sexes, showing a
moderate correlation in males, but essentially zero cor-
relation for females. Thus, main body weight increases
on HFD challenge occurs during weeks 0–6, while the
total result of body weight accumulation can be set by
the body weight dynamics during the 2nd period. We
speculate that there are 3 main options during 2nd
period: 1) High body weight defense by body weight de-
cline shown by some female lines; 2) Moderate body
weight defense by inhibiting/restraining body weight
increase shown some females and males lines and 3)
Continuous body weight increase since challenge start
point. In females, the choice of options appears to be
independent of gains in the first 6 weeks, while in males
there is a moderate correlation with first 6-week gains
but considerable leeway for individual variation. These
sex differences might be due to the different hormone
expression variations in both sexes, as suggested in hu-
man studies [17, 70, 71]
Conclusions
Under Chow diet, both sexes of all lines did not show
impaired IPGTT tests. There was very wide statisti-
cally significant variation among the individual lines
in their response to HFD (Figs. 1–5). Broad sense
heritability coefficients (H2) at the level of the indi-
vidual mouse are in the moderate range (Table 1), in-
dicating that target traits are affected more or less
equally by genetic and environmental factors and
their interaction. At the level of line, however, herit-
ability coefficients (H2n) are very high, indicating that
observed variation among line-means is primarily gen-
etic in origin. Genetic coefficient of variation (CVG)
of CC population is about twice the value than in
quantitative traits of wild or domesticated animal
populations, probably due to the inclusion of the wild
accessions in the formation of the CC lines. Two-
stage control of weight gains were shown under HFD,
the first 6 weeks, where both sexes of all lines gained
weight, and second 6 weeks, where most male lines
continued to gain weight, while the females varied in
line behavior - some lost weight, some maintained
weight, and only a few continued to gain weight. Females
were much more able to control BW gains under HFD.
Our results demonstrates the important role of sex differ-
ences in the physiology of MTS and T2D, that must be
considered in advanced studies [72, 73].
Our results confirm that host susceptibility to high
fat diet-induced T2D is a complex trait controlled by
multiple genetic factors and that the CC population
will be a powerful and promising tool for dissecting
this trait, as shown in previous studies of other traits
[40, 42, 53, 74, 75].
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